EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chemoproteomics of Marine Natural Product Naamidine J Unveils CSE1L as a Therapeutic Target in Acute Lung Injury

Cheng-Long Gao, Jin-Qian Song, Ze-Nan Yang, Haojie Wang, Xin-Yuan Wu, Changwei Shao, Hong-Xia Dai, Kaixian Chen, Yue-Wei Guo iD, Tao Pang iD, Xu-Wen Li iD

Journal of the American Chemical Society · 16.10.2024 · 146 (41) · 28384-28397

DOI: 10.1021/jacs.4c09695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 26.09.2024. Verfasst von Cheng-Long Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing 210009…. Hauptthemen laut MEDLINE: Acute Lung Injury. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, State Key Laboratory of Natural Medicines, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute lung injury is a devastating illness characterized by severe inflammation mediated by aberrant activation of macrophages, resulting in significant morbidity and mortality, highlighting the urgent need for novel pharmacological targets and drug candidates. In this study, we identified a novel target for regulating inflammation in macrophages and acute lung injury via chemical proteomics and genetics based on a marine alkaloid, naamidine J (NJ). The structures of NJ-related naamidine alkaloids were first confirmed or revised by a combination of quantum chemical calculations and X-ray diffraction analysis. NJ was found as a potential anti-inflammatory agent by screening our compound library, and CSE1L was identified by chemoproteomics as a main cellular target of NJ to inhibit inflammation in macrophages and protect against acute lung injury. Mechanistically, we demonstrated that NJ directly interacted with CSE1L on the sites of His745 and Phe903 and then inhibited the nuclear translocation and transcriptional activity of transcription factor SP1, thereby suppressing inflammation in macrophages and ameliorating acute lung injury. Taken together, these findings have uncovered a novel pharmacological target for the treatment of acute lung injury and have also provided a potential druggable pocket of CSE1L and a lead compound or an available chemical tool from marine sources for investigating CSE1L function and developing novel drug candidates against acute lung injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryAnimalsMiceBiological ProductsHumansSp1 Transcription FactorMacrophagesProteomicsRAW 264.7 CellsAnti-Inflammatory AgentsAlkaloids

Substanzen

Biological ProductsSp1 Transcription FactorAnti-Inflammatory AgentsAlkaloids

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines, New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing 210009, P. R. China.
  • State Key Laboratory of Chemical Biology, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, P. R. China.
  • University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
  • Department of Medicinal Chemistry, School of Pharmacy, Fudan University, Shanghai 201203, P. R. China.
  • School of Medicine, Shanghai University, Shanghai 200444, P. R. China.

ORCID-Profile: Yue-Wei Guo, Tao Pang, Xu-Wen Li

Förderung

  • National Key Research and Development Program of China
  • State Key Laboratory of Natural Medicines
  • China Pharmaceutical University
  • China Postdoctoral Science Foundation
  • Taishan Scholar Project of Shandong Province
  • National Natural Science Foundation of China
  • Shanghai Super Postdoc Incentive Program
  • Shandong Laboratory Program

Zitieren

APA

Gao, C. L., Song, J. Q., Yang, Z. N., Wang, H., Wu, X. Y., Shao, C., Dai, H. X., Chen, K., Guo, Y. W., Pang, T., & Li, X. W. (2024). Chemoproteomics of Marine Natural Product Naamidine J Unveils CSE1L as a Therapeutic Target in Acute Lung Injury. Journal of the American Chemical Society, 146(41), 28384-28397. https://doi.org/10.1021/jacs.4c09695

Vancouver

Gao CL, Song JQ, Yang ZN, Wang H, Wu XY, Shao C, et al. Chemoproteomics of Marine Natural Product Naamidine J Unveils CSE1L as a Therapeutic Target in Acute Lung Injury. Journal of the American Chemical Society. 2024;146(41):28384-28397. doi:10.1021/jacs.4c09695

BibTeX
@article{Gao2024,
  author = {Gao, Cheng-Long and Song, Jin-Qian and Yang, Ze-Nan and Wang, Haojie and Wu, Xin-Yuan and Shao, Changwei and Dai, Hong-Xia and Chen, Kaixian and Guo, Yue-Wei and Pang, Tao and Li, Xu-Wen},
  title = {Chemoproteomics of Marine Natural Product Naamidine J Unveils CSE1L as a Therapeutic Target in Acute Lung Injury},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {41},
  pages = {28384--28397},
  doi = {10.1021/jacs.4c09695}
}
Kostenlos starten →